TUESDAY, Dec. 13, 2022 (HealthDay News) — Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma. Moderna, well known for its work on the COVID vaccine, and Merck, which makes the cancer immunotherapy drug Keytruda, announced that the combination performed wellContinue Reading
TUESDAY, Dec. 13, 2022 (HealthDay News) — Black patients are more likely than their white peers to need emergency surgery for colon cancer, which increases their risk for complications and death, study authors say. “Overall, these results suggest that racial and ethnic differences persist” among colon cancer patients, and “theseContinue Reading
MONDAY, Dec. 12, 2022 (HealthDay News) — For those who care about their teeth, a new study sounds a pretty clear alarm: using tobacco in any form — including the increasingly popular practice of vaping — is a recipe for a dental nightmare. The warning comes from the U.S. NationalContinue Reading
MONDAY, Dec. 12, 2022 (HealthDay News) — If someone is stricken with a blood cancer or life-threatening clot, they’ll probably fare better if they are white and wealthy, three new studies show. The ongoing impact of patient race and income to medical outcomes was in the spotlight Saturday in NewContinue Reading
FRIDAY, Dec. 9, 2022 (HealthDay News) — Mastectomy has long been the standard of care for certain breast cancer patients, but it still may be more extensive than many women need, a new study suggests. Researchers found that many women who have two or even three breast tumors may beContinue Reading
FRIDAY, Dec. 9, 2022 (HealthDay News) — Black patients with brain tumors may be less likely to have surgery recommended to them than white patients are, according to a large U.S. study. The research, which looked at two national databases, found that on average, Black patients were less likely toContinue Reading
FRIDAY, Dec. 9, 2022 (HealthDay News) — A new genetic test may help determine which people with breast cancer can safely skip radiation after breast-conserving surgery to remove their tumor. Individuals with invasive breast cancer who had low scores on an investigational gene panel were just as likely to experienceContinue Reading
THURSDAY, Dec. 8, 2022 (HealthDay News) — A relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven’t responded to other treatments, according to a pair of clinical trials. The targeted antibody drug — trastuzumab deruxtecan (T-DXd, sold under the brandContinue Reading
THURSDAY, Dec. 8, 2022 (HealthDay News) — An experimental therapy that uses the body’s own immune system cells may beat a standard treatment for patients with advanced melanoma, a new clinical trial finds. Researchers found that the therapy doubled the amount of time melanoma patients lived without their skin cancerContinue Reading
THURSDAY, Dec. 8, 2022 (HealthDay News) — A proposed U.S. federal ban on menthol cigarettes doesn’t go far enough and needs to include other menthol products, from pipe tobacco to cigarette tubes, researchers say. New evidence shows both the appeal and the addiction potential of these substitutes in adults whoContinue Reading